Brief: Zura Bio Welcomes Accomplished Drug Development Leaders To Board Of Directors
23/02/2026 11:38
Feb 23 (Reuters) - Zura Bio Ltd ZURA.O: ZURA BIO WELCOMES ACCOMPLISHED DRUG DEVELOPMENT LEADERS MARK EISNER, M.D., M.P.H., AND AJAY NIRULA, M.D., PH.D., TO BOARD OF DIRECTORS Source text: ID:nBw1c7r5Ka Further company coverage: ZURA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zura Bio
See all newsZura Bio Ltd reports results for the quarter ended June 30 - Earnings Summary
Zura Bio Q2 net loss widens as R&D expenses rise
Zura Bio Ltd expected to post a loss of 20 cents a share - Earnings Preview
Brief: Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Zura Bio Expands Leadership Team With Appointment Of Muzammil Mustufa As Chief Business Officer